We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
17
Jul 2026
"Turn off that TV, it'll rot your brain!" has been a household refrain for decades. While "rot" might be too strong a term, researchers are finding that the overall sentiment could have some merit.
17
Jul 2026
Scientists have long known that the human brain continues developing well beyond the teenage years, with important changes involving decision-making and emotional regulation extending into the mid-to-late 20s.
17
Jul 2026
Many of the world's leading causes of irreversible blindness, including glaucoma and age-related macular degeneration, share a common problem: the buildup of fluid, waste and inflammatory debris in the back of the eye.
17
Jul 2026
When cardiac arrest strikes outside of a hospital, survival rates remain unacceptably low, often because CPR is not administered immediately, according to the American Heart Association.